Mutual Funds Sahi Hai!
To avail the service, you will be redirected to loans.geojitcredits.com
Torrent Pharmaceuticals is the flagship of the Torrent Group and ranks seventh in the Indian pharmaceutical market. It is among the top five players in key therapeutic areas such as cardiovascular, gastrointestinal, central nervous system, and cosmo-dermatology. With nearly 76% of its India business coming from chronic and sub-chronic therapies, Torrent remains a focused, specialty-driven player.
The pharma major reported a net profit of Rs 548 crore in Q1 FY25, marking a 20% year-on-year increase. Revenue for the quarter stood at Rs 3,178 crore, an 11% rise over Q1 FY25.
The scrip slipped 1.34% to Rs 3,624.85 on the BSE.
International markets played a key role in the growth story. Sales in the United States rose 19% to Rs 308 crore. India, Torrent’s largest market, contributed Rs 1,811 crore, growing 11% year-on-year. Brazil matched that growth with an 11% rise, while Germany posted a 9% increase. Revenue from other global markets was also healthy, rising 10% YoY.
On the operational front, EBITDA grew 14% YoY to Rs 1,032 crore, translating into a margin of 32.5%. Adjusting for one-time acquisition-related expenses of Rs 15 crore, the margin edged higher to 32.9%. Gross margins remained firm at 76% in Q1 FY26.
The company also continued to back its R&D engine, spending Rs 157 crore during the quarter, a 16% increase over last year, while maintaining the R&D-to-sales ratio at 5%.
Torrent's performance drew praise from analysts. A foreign brokerage firm raised its price target on the stock to Rs 4,380 from Rs 4,000, citing the quarter as 'healthy and in-line,' with 'solid traction across geographies.' The firm maintained its 'Buy' rating, reflecting optimism over the company’s steady execution and global growth outlook.
Torrent Pharmaceuticals Ltd is up for a third straight session today. The stock is quoting at Rs 3758.6, up 3.75% on the day as on 12:49 IST on the NSE. The benchmark NIFTY is up around 0.08% on the day, quoting at 24701.85. The Sensex is at 80911.87, up 0.03%. Torrent Pharmaceuticals Ltd has gained around 10.28% in last one month.
Meanwhile, Nifty Pharma index of which Torrent Pharmaceuticals Ltd is a constituent, has gained around 4.35% in last one month and is currently quoting at 22761.15, up 1.04% on the day. The volume in the stock stood at 11.8 lakh shares today, compared to the daily average of 6.26 lakh shares in last one month.
The benchmark July futures contract for the stock is quoting at Rs 3766.6, up 3.95% on the day. Torrent Pharmaceuticals Ltd is up 20.81% in last one year as compared to a 0.63% slide in NIFTY and a 6.77% slide in the Nifty Pharma index.
The PE of the stock is 64.84 based on TTM earnings ending March 25.